By 2028, Diabetes Care Devices Market is expected to surpass USD 45.09 Billion with a CAGR of 8.1% over the forecast period.
Global Diabetes Care Devices Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Increasing use of stick-free glucose testing, rising prevalence of diabetics, and growing technological advancements are some of the major factors driving the growth of the Global Diabetes Care Devices Market.
Diabetes Care Devices Market Key Players:
• Acon Laboratories, Inc.
• Becton, Dickinson, and Company
• Dexcom, Inc.
• Johnson & Johnson
• Medtronic Plc
• Novo Nordisk A/S
• Terumo Corporation
• Hoffmann-La Roche Ltd.
• Ascensia Diabetes Care Holdings Ag
• Abbott Laboratories
Get Sample Copy of Report: https://brandessenceresearch.com/requestSample/PostId/2068
Global Diabetes Care Devices Market Segmentation:
By Product
- Blood Glucose Monitoring Devices
- Testing Strips
- Lancets
- Self-monitoring Blood Glucose Meters
- Continuous Glucose Monitors
- Insulin Delivery Devices
- Insulin Syringes
- Insulin Pens
- Insulin Jet Injectors
- Insulin Pumps
By End-Use
- Retail Pharmacies
- Hospital pharmacies
- Diabetes Clinics/Centers
- Online Pharmacies
Buy This Report Now: https://brandessenceresearch.com/Checkout?report_id=2068
Scope of Global Diabetes Care Devices Market Report-
Diabetes care devices are basically used to determine the blood sugar level in the body due to insulin production. Diabetes care devices are provided to diabetic patients to effectively monitor blood glucose levels and improve treatment for this chronic condition. A continuous glucose monitor (CGM) is a medical device that monitors and monitors a diabetic patient’s blood glucose throughout the day. This wearable device is particularly useful for people with diabetes as it can help them manage glucose levels.
The covid-19 pandemic has shown a positive impact on the growth of the global diabetes care devices market. This is because patients with a variety of health problems, including diabetes and high blood pressure, have a higher risk of contracting the virus. Patients with diabetes have a higher mortality rate than the general population. People with diabetes need constant insulin and care. Thus, the demand for close monitoring & optimal management of diabetes increased the adoption of insulin pens & continuous glucose monitoring devices during a pandemic.
The global diabetes care devices market is segmented on the product, end-use, and region & country level. Based on the product, the global diabetes care devices market is segmented into blood glucose monitoring devices and insulin delivery devices. Blood glucose monitoring devices are further subdivided into testing strips, lancets, self-monitoring blood glucose meters, and continuous glucose monitors. Insulin delivery devices are further subdivided into insulin syringes, insulin pens, insulin jet injectors, and insulin pumps.
Get Methodology at: https://brandessenceresearch.com/requestMethodology/PostId/2068
News-
Zyla Partnered with Accu-Chek to Revolutionize Diabetes Care Through IoT.
On March 24th, 2022; Zyla Health is revolutionizing the management of diabetes and related diseases through its technological innovation and constant care. Zyla has launched a joint offer with Accu-Chek, which offers the best in both worlds for diabetics – A smart glucometer and continuous diabetes care under the authority of leading doctors and specialists that enable you to effectively manage a long-term condition such as diabetes. The offer was launched on Amazon and Flipkart and is now available for users across the country to take advantage of.
Roche Announced the Launch of Connected Blood Glucose Monitoring System.
On March 11th, 2021; Roche announced the launch of the new Accu-Chek Instant system, a new “connected” blood glucose monitoring (BGM) system, which supports and enables Roche’s approach of integrated Personalised Diabetes Management (iPDM). Accu-Chek Instant features Bluetooth-enabled connectivity to the mySugr app, allowing wireless transfer of blood glucose results to the mySugr app. This app offers users quick insights into their diabetes data in addition to diabetes management features like the mySugr insulin calculator.
First Implantable Continuous Glucose Monitor Received FDA Approval for Type 1 and Type 2 Diabetes.
On January 23rd, 2019; The U.S. Food and Drug Administration approved the first implantable continuous glucose monitoring (CGM) device for people with type 1 and type 2 diabetes. The device, called the Eversense Continuous Glucose Monitoring System, provides monitoring for up to three months, and it’s approved for people age 18 and older, according to an FDA press release on June 21st.
Increasing Use of Stick-Free Glucose Testing, Rising Cases of Diabetes, and Growing Technological Advancements are Some of the Major Factors Driving the Market Growth
One of the major factors driving the growth of the diabetes care devices market is the increasing use of stick-free glucose testing. Stick-free glucose testing is beneficial because repeatedly using needle sticks to check blood sugar is unpleasant. Testing blood sugar helps patients make lifestyle decisions such as what to eat, how often to exercise, and the amount of insulin. Continuous glucose monitoring (CGM) helps patients avoid stickiness.
In addition, the rising cases of diabetes are boosting the growth of the diabetes care devices market. Obesity, a sedentary lifestyle, and aging are some of the leading causes of diabetes worldwide. After all, obesity is a major factor in the development of diabetes in individuals. Obesity and being overweight are some of the risk factors associated with diabetes. Diabetes is a chronic condition in which the pancreas does not produce enough insulin or use it efficiently to regulate sugar in the body. Type 2 diabetes is caused by the body’s poor use of insulin.
However, the lack of reimbursement & strict regulations in some countries, and rising obesity rates associated with diabetes care devices may hinder the growth of the global diabetes care devices market. Despite that, increasing R&D investments and research collaborations may create more opportunities for the further growth of the market.
On Special Requirement Global Diabetes Care Devices Market. The report is also available for the below Regions and Countries: –
North America
- US.
- Canada
Europe
- Germany
- France
- UK.
- Italy
- Spain
- Sweden
- Netherland
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest Of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest Of MEA
Get Full Access to all Reports: https://brandessenceresearch.com/diabetes/diabetes-care-devices-market
Related Reports:
- Oncology Nutrition Market was worth USD 1.35 billion in 2021 and it is expected to reach USD 2.24 billion at the end of 2028 with a CAGR of 7.45%.
- Global Medical Wearables Market is valued at USD 20.1 Billion in 2021 and is expected to reach USD 103.8 Million by 2028 with a CAGR of 26.43% over the forecast period.
- Consumer Genomics Market is valued at USD 2259.0 Million in 2021 and expected to reach USD 7806.3 Million by 2028 with a CAGR of 19.38% over the forecast period.
- Global Healthcare CRM Market is valued at USD 12.53 Billion in 2021 and is expected to reach USD 31.54 Billion by 2028 with a CAGR of 14.1% over the forecast period.
- The Global Metaverse in Healthcare Market is valued at USD 5056.4 Million in 2021 and is expected to reach USD 7453.6 Million by 2028 with a CAGR of 33.7% over the forecast period.
- mRNA Vaccines & Therapeutics Market is valued at USD 64.6 Million in 2020 and expected to reach USD 1599.2 Million by 2027 with a CAGR of 29.83% over the forecast period.
- Global Insulin Pump Market was worth USD 4.98 billion in 2021 and it is expected to reach USD 12.18 billion at the end of 2028 with a CAGR of 13.64%.
- Global Soft Tissue Repair Market is valued at USD 10.79 Billion in 2021 and expected to reach USD 17.68 Billion by 2028 with a CAGR of 7.3% over the forecast period.
- Atopic Dermatitis Market is valued at USD 6.54 Billion in 2021 and expected to reach USD 16.23 Billion by 2028 with a CAGR of 13.87% over the forecast period.
- Global Vaccines Market is valued at USD 56.98 Billion in 2021 and expected to reach USD 153.49 Billion by 2028 with a CAGR of 14.1% over the forecast period.
i-Factor: Live Market intelligence platform
I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register or free trial here at https://brandessenceresearch.com/i-factor/login/userRegister
Brandessence Market Research & Consulting Pvt ltd.
Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be the best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Follow Us: LinkedIn
Contact Us:
Email: Sales@brandessenceresearch.com
Corporate Sales: +44-2038074155
Asia Office: +917447409162